Clinical Trials
12 trialsNCT07294170 2026-06-03
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
argenx
Recruiting
NCT07595653 2026-05-19
POEMA
argenx
Recruiting
NCT00704626 2026-05-18
SAA
University of California, Davis
Enrolling by invitation
NCT06909253 2026-05-15
MG-ARCADIA
AstraZeneca
Recruiting
NCT07247279 2026-05-13
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
Recruiting
NCT07570589 2026-05-11
REAL MG PRO
Centre Hospitalier Universitaire de Nice
Not yet recruiting
NCT06866652 2026-05-08
MyaRESP
Institut de Myologie, France
Recruiting
NCT07571525 2026-05-06
TAILOR-MG
IRCCS San Raffaele
Not yet recruiting
NCT06312644 2026-04-16
Study of UltomirisĀ® (Ravulizumab) Safety in Pregnancy
Alexion Pharmaceuticals, Inc.
Recruiting
NCT07512375 2026-04-06
MY-EDUC
University Hospital, Grenoble
Not yet recruiting
NCT06700616 2026-03-16
MG Cohort
AstraZeneca
Active not recruiting
NCT07472777 2026-03-16
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
Completed